A randomized, open-label study to compare the effects of two different doses of recombinant human growth hormone on fat reduction and fasting metabolic parameters in HIV-1-infected patients with lipodystrophy.
about
In vitro and in vivo effects of IGF-I on adiposity in HIV-associated metabolic disease: a pilot studyLipodystrophy: pathophysiology and advances in treatmentLeptin in relation to the lipodystrophy-associated metabolic syndromeApproach to the human immunodeficiency virus-infected patient with lipodystrophyGrowth Hormone's Effect on Adipose Tissue: Quality versus Quantity.Long-term effect on body composition and metabolic parameters after treatment with recombinant human growth hormone (r-hGH) in HIV-1 infected patients with lipodystrophy.
P2860
A randomized, open-label study to compare the effects of two different doses of recombinant human growth hormone on fat reduction and fasting metabolic parameters in HIV-1-infected patients with lipodystrophy.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
A randomized, open-label study ...... d patients with lipodystrophy.
@en
A randomized, open-label study ...... d patients with lipodystrophy.
@nl
type
label
A randomized, open-label study ...... d patients with lipodystrophy.
@en
A randomized, open-label study ...... d patients with lipodystrophy.
@nl
prefLabel
A randomized, open-label study ...... d patients with lipodystrophy.
@en
A randomized, open-label study ...... d patients with lipodystrophy.
@nl
P2093
P2860
P1433
P1476
A randomized, open-label study ...... d patients with lipodystrophy.
@en
P2093
Staszewski S
P2860
P304
P356
10.1111/J.1468-1293.2006.00399.X
P577
2006-09-01T00:00:00Z